Recent Updates
Recently added Catalysts
OGI Positive Sentiment Score: 60/100

NOTICE OF CHANGE IN YEAR-END PURSUANT TO SECTION 4.8 OF NATIONAL INSTRUMENT 51-102 ORGANIGRAM HOLDINGS INC. 1. Change in Financial Year-End Notice is hereby provided pursuant to section 4.8 of National Instrument 51-102

Key Takeaway: Organigram Holdings Inc. has announced a change in its financial year-end from August 31 to September 30. This shift is intended to better align the company's financial reporting with other public companies and standard calendar quarters. The change is expected to enhance the comparability and transparency of the company's financial statements.

Market Sentiment Analysis

POSITIVE FACTORS

  • The change aligns financial reporting with peers and calendar quarters.
  • It aims to improve comparability and transparency in financial statements.

Full Press Release Details

NOTICE OF CHANGE IN YEAR-END
PURSUANT TO SECTION 4.8 OF NATIONAL INSTRUMENT 51-102
ORGANIGRAM HOLDINGS INC.
Notice is hereby provided pursuant to section 4.8 of National Instrument 51-102 Continuous Disclosure Obligations ("NI 51-102")
that Organigram Holdings Inc. (the "Issuer") has decided to change its financial year end from August 31 to September 30.
The change is being undertaken by the Issuer on the basis that it will better align the Issuer's
financial statement reporting requirements with other public companies and calendar quarters.
Period and Ending Date Length Filing Deadlines Comparative Period and Ending Date
First quarter interim financial statements for the period ended November 30, 2022 3 months January 14, 2023 3 months ended November 30, 2021
Second quarter interim financial statements for the period ended February 28, 2023 6 months April 14, 2023 6 months ended February 28, 2022
Third quarter interim financial statements for the period ended May 31, 2023 9 months July 15, 2023 9 months ended May 31, 2022
Annual financial statements for the year ended September 30, 2023 (i.e., for the 13-months ended September 30, 2023) 13 months December 29, 2023 12 months ended August 31, 2022
Period and Ending Date Length Filing Deadlines Comparative Period and Ending Date
First quarter interim financial statements for the period ended December 31, 2023 3 months February 14, 2024 3 months ended November 30, 2022
Second quarter interim financial statements for the period ended March 31, 2024 6 months May 15, 2024 6 months ended February 28, 2023
Third quarter interim financial statements for the period ended June 30, 2024 9 months August 14, 2024 9 months ended May 31, 2023
Annual financial statements for the year ended September 30, 2024 12 months December 29, 2024 13 months ended September 30, 2023

Frequently Asked Questions

Why has Organigram changed its financial year-end?

The change to September 30 aligns financial reporting with other public companies.

When is the new filing deadline for annual statements?

The annual financial statements for the year ended September 30, 2024, are due December 29, 2024.

What is the first quarter ending date for 2023?

The first quarter for 2023 ends on November 30, 2022.

What was the previous financial year-end date?

The previous financial year-end was August 31.

When are financial statements for May 2023 due?

The third quarter statements for May 31, 2023, are due on July 15, 2023.

Last updated: May 15, 2023